Synlogic

Synlogic A biotech company focused on new ways to improve treatment for rare metabolic diseases like PKU & HCU

Last week we announced the decision to end Synpheny-3, our pivotal study in phenylketonuria (PKU), and that as a result,...
02/12/2024

Last week we announced the decision to end Synpheny-3, our pivotal study in phenylketonuria (PKU), and that as a result, Synlogic will be evaluating strategic options for the company and ceasing operations (see below press release).

We express our sincere appreciation to everyone who has worked for and with Synlogic, as we have advanced science, while building a special company and place to work.

We extend particular gratitude to the PKU & HCU communities, who inspired us, and whose partnership enabled our pursuit of a shared aspiration to bring forward a meaningful new class of medicines. For more information, please read: https://loom.ly/FZtxgso

02/05/2024

The Synpheny-3 Clinical Trial is now available in Nashville, TN! Virtual, hybrid, and in-person options for participation are available.

Scan the QR code or visit www.pkuresearchstudy.com to learn more.

02/02/2024

The Synpheny-3 Clinical Trial is now available in Chicago, IL! Virtual, hybrid, and in-person options for participation are available.

Scan the QR code to learn more!

Congratulations to the authors!  Proud to see this manuscript summarizing the journey of SYNB1353, our drug candidate fo...
02/02/2024

Congratulations to the authors! Proud to see this manuscript summarizing the journey of SYNB1353, our drug candidate for classical , from concept through positive Proof of Mechanism, published in Cell Host & Microbe! Read more here: https://loom.ly/dU6m0Mg Cell Press

02/01/2024

Congratulations Maks! Thank you for your remarkable and many contributions over the last five years!

01/31/2024

The Synpheny-3 Clinical Trial is recruiting in Calgary! Scan the QR code to learn more and to speak to Synlogic's clinical trial case manager.

01/30/2024

A reminder to those affected by !

01/29/2024

The Synpheny-3 Clinical Trial is now available in Gainesville, FL! Virtual, hybrid, and in-person options for participation are available.

Scan the QR code to learn more and to speak to Synlogic's clinical trial case manager.

01/26/2024

The Synpheny-3 Clinical Trial is now available in Charleston, SC! Virtual, hybrid, and in-person options for participation are also available.

Scan the QR code to learn more and to speak to Synlogic's clinical trial case manager.

Curious about the Synpheny-3 clinical trial? In this video, we answer some of the questions we often receive from the PK...
01/25/2024

Curious about the Synpheny-3 clinical trial? In this video, we answer some of the questions we often receive from the PKU community.

Learn more: https://loom.ly/m9Fq1Bk

01/24/2024

Learn more about our ongoing, pivotal study in in this brief (~2 min) video: https://loom.ly/1Uzqggk or visit pkuresearchstudy.com

01/24/2024

The Synpheny-3 Clinical Trial is now available in Aurora, CO! Virtual, hybrid, and in-person options for participation are available.

Scan the QR code to learn more and to speak to Synlogic's clinical trial case manager. CU Medicine

Address

301 Binney Street, #402
Cambridge, MA
02142

Opening Hours

Monday 8am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Alerts

Be the first to know and let us send you an email when Synlogic posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Featured

Share